Schedule 13G Filing by CVI Investments, Inc. and Heights Capital Management, Inc. for Citius Pharmaceuticals, Inc.

CVI Investments, Inc. and Heights Capital Management, Inc. have filed a Schedule 13G with the SEC, reporting beneficial ownership of 9.9% of the common stock of Citius Pharmaceuticals, Inc. The filing indicates that Heights Capital Management, Inc. serves as the investment manager for CVI Investments, Inc. and may exercise voting and dispositive power over the shares owned by CVI Investments, Inc. The shares reported include 1,460,000 shares and shares issuable upon the exercise of pre-funded warrants and other warrants, which are subject to a 9.99% ownership limitation. The filing also includes a Limited Power of Attorney and a Joint Filing Agreement.